Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
10/06/2011 | US20110245327 Oligonucleotide Analogues |
10/06/2011 | US20110245326 Post-Transcriptional Regulation Of RNA-Related Processes Using Encoded Protein-Binding RNA Aptamers |
10/06/2011 | US20110245325 Pharmaceutical composition for treatment of cancer and asthma |
10/06/2011 | US20110245322 Methods for identifying and compounds useful for increasing the functional activity and cell surface expression of cf-associated mutant cystic fibrosis transmembrane conductance regulator |
10/06/2011 | US20110245320 Nuclease resistant double-stranded ribonucleic acid |
10/06/2011 | US20110245318 Rna sequence-specific mediators of rna interference |
10/06/2011 | US20110245174 Glp-1 fusion polypeptides |
10/06/2011 | US20110245168 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
10/06/2011 | US20110245146 Non-Viral Delivery of Compounds to Mitochondria |
10/06/2011 | US20110245145 Methods and reagents for the diagnosis, prevention and treatment of insulin resistance |
10/06/2011 | US20110245094 Detection of microbial nucleic acids |
10/06/2011 | US20110245086 Short cycle methods for sequencing polynucleotides |
10/06/2011 | US20110244568 Rna sequence-specific mediators of rna interference |
10/06/2011 | US20110244564 Cystine knot molecules |
10/06/2011 | US20110244563 Assays that use the t1r1 receptor polypeptides to screen for t1r1-associated taste modulators |
10/06/2011 | US20110244562 Rna interference suppression of neurodegenerative diseases and methods of use thereof |
10/06/2011 | US20110244561 siRNA-MEDIATED GENE SILENCING |
10/06/2011 | US20110244550 Factor ix polypeptide mutant, its uses and a method for its production |
10/06/2011 | US20110244545 Polymeric carriers for immunohistochemistry and in situ hybridization |
10/06/2011 | US20110244544 Polymeric carriers for immunohistochemistry and in situ hybridization |
10/06/2011 | US20110244537 Regio- and enantioselective alkane hydroxylation with modified cytochrome p450 |
10/06/2011 | US20110244530 L-succinylaminoacylase and process for producing l-amino acid using it |
10/06/2011 | US20110244519 Use of rna trans-splicing for antibody gene transfer and antibody polypeptide production |
10/06/2011 | US20110244474 Rapid screening of biologically active nucleases and isolation of nuclease-modified cells |
10/06/2011 | US20110244463 Method for columbidae gender identification, nucleotide sequence for columbidae gender and nucleotide primer pair for columbidae gender |
10/06/2011 | US20110244460 Method for detecting controls for nucleic acid amplification and use thereof |
10/06/2011 | US20110244458 Methods and Nucleic Acids for Analyses of Cellular Proliferative Disorders |
10/06/2011 | US20110244456 Herbicide tolerant cotton plants and methods for identifying same |
10/06/2011 | US20110244453 Salmonella detection assay |
10/06/2011 | US20110244449 Methods of determining copy number of a genetic locus |
10/06/2011 | US20110244446 Rna sequence-specific mediators of rna interference |
10/06/2011 | US20110244025 Modified oligoribonucleotide analogs with enhanced immunostimulatory activity |
10/06/2011 | US20110243995 Method for Rational Mutagenesis of Alpha/Beta T-Cell Receptors and Correspondingly Mutated MDM2-Protein Specific Alpha/Beta T-Cell Receptors |
10/06/2011 | US20110243986 Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use |
10/06/2011 | US20110243972 Prostate stem cell antigen vaccines and uses thereof |
10/06/2011 | US20110243968 Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer |
10/06/2011 | US20110243966 SINGLE CHAIN Fc (ScFc) REGIONS, BINDING POLYPEPTIDES COMPRISING SAME, AND METHODS RELATED THERETO |
10/06/2011 | US20110243962 Therapeutic use of specific ligand in msrv associated diseases |
10/06/2011 | US20110243955 Antibody and uses thereof |
10/06/2011 | US20110243953 Neutralizing antibodies against gdf-8 and uses therefor |
10/06/2011 | US20110243950 Msp2 antigenic peptides and their use |
10/06/2011 | US20110243945 Anti-Inflammatory Agents |
10/06/2011 | US20110243944 Fusion Protein Inhibiting Osteoclast Formation, Preparation Method and Medicine Compositions Thereof |
10/06/2011 | US20110243941 Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same |
10/06/2011 | US20110243932 Anti-cd40 antibodies |
10/06/2011 | US20110243930 Compositions and methods for the treatment of immune related diseases |
10/06/2011 | US20110243929 Anti-icos antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
10/06/2011 | US20110243926 Anti-p-selectin antibodies and methods of using the same to treat inflammatory diseases |
10/06/2011 | US20110243923 Organic compounds |
10/06/2011 | US20110243922 Genetic Alterations Associated with Type I Diabetes and Methods of Use Thereof for Diagnosis and Treatment |
10/06/2011 | US20110243916 Modified endolysin ply511 |
10/06/2011 | US20110243912 Growth Factor Binding Constructs Materials and Methods |
10/06/2011 | US20110243904 Rna interference target for treating aids |
10/06/2011 | US20110243899 Wnt Signaling Inhibitor Comprising Insulin-Like Growth Factor-Binding Protein |
10/06/2011 | US20110243888 Il-29 mutants and uses thereof |
10/06/2011 | US20110243887 Il-7 fusion proteins |
10/06/2011 | US20110243842 Mammalian receptor proteins; related reagents and methods |
10/06/2011 | CA2794800A1 Method for improving detection of b cell immunoglobulin gene recombination |
10/06/2011 | CA2794311A1 Macrocyclic lactone resistance marker for dirofilaria immitis |
10/06/2011 | CA2792291A1 Sirna therapy for transthyretin (ttr) related ocular amyloidosis |
10/05/2011 | EP2371835A1 Inhibition of syk kinase expression |
10/05/2011 | EP2371834A1 Stabilized immunomodulatory oligonucleotides |
10/05/2011 | EP2371387A2 HIV consensus sequence antigens and their use in vaccina |
10/05/2011 | EP2370451A2 Method for the synthesis of phosphorus atom modified nucleic acids |
10/05/2011 | EP1841463B1 Methods and compositions for treating, inhibiting and reversing disorders of the intervertebral disc |
10/05/2011 | EP1828389B1 Sparc promoter mutations associated with drug resistance, and methods associated therewith |
10/05/2011 | EP1660682B1 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION |
10/05/2011 | EP1578943B1 Novel variant hypocrea jecorina cbh1 cellulases |
10/05/2011 | EP1417333B1 Pna probes, probe sets, methods and kits pertaining to the detection of candida |
10/05/2011 | EP1373296B1 Proteins producing an altered immunogenic response and methods of making and using the same |
10/05/2011 | EP1239952B1 Oligonucleotide synthesizer using centrifugal force |
10/05/2011 | EP1177203B1 Collagen-binding proteins from enterococcal bacteria |
10/05/2011 | CN1950510B Glutamine-rich maize seed protein and promoter |
10/05/2011 | CN102209894A Biomarkers for assessing atherosclerotic potential |
10/04/2011 | US8030539 Method for the stable expression of nucleic acids in transgenic plants, controlled by a parsley-ubiquitin promoter |
10/04/2011 | US8030479 Method of separating small RNA molecules using kosmotropic salt |
10/04/2011 | US8030478 Method for nucleic acid replication and novel artificial base pairs |
10/04/2011 | US8030477 Methods for the synthesis of arrays of DNA probes |
10/04/2011 | US8030476 siRNA targeting gremlin |
10/04/2011 | US8030475 Inhibitors of retroviral reverse transcriptase |
10/04/2011 | US8030474 siRNA targeting cyclin-dependent kinase 4 (CDK4) |
10/04/2011 | US8030471 Plasmodium malariae and Plasmodium ovale genes and uses thereof |
10/04/2011 | US8030469 Anti-CD26 antibodies and methods of use thereof |
10/04/2011 | US8030468 Human T2R51 taste receptor nucleic acid sequences and polypeptides |
10/04/2011 | US8030467 5′-modified bicyclic nucleic acid analogs |
10/04/2011 | US8030466 3′-o-fluorescently modified nucleotides and uses thereof |
10/04/2011 | US8030465 Nucleic acid ligands to complex targets |
10/04/2011 | US8030464 Stabilized bioactive peptides and methods of identification, synthesis, and use |
10/04/2011 | US8030463 Method for detecting and quantifying endogenous wheat DNA sequence |
10/04/2011 | US8030462 Immunotherapy; induce immunology response |
10/04/2011 | US8030461 Methods for constructing scDb libraries |
10/04/2011 | US8030460 Compounds and methods for labeling oligonucleotides |
10/04/2011 | US8030456 Nogo receptor antagonists |
10/04/2011 | US8030451 Isolated bitter taste receptor polypeptides |
10/04/2011 | US8030325 Biosynthetic gene cluster for the production of a complex polyketide |
10/04/2011 | US8030292 Antisense antiviral compounds and methods for treating a filovirus infection |
10/04/2011 | US8030291 Antisense antiviral compounds and methods for treating a filovirus infection |
10/04/2011 | US8030290 Cell-type specific aptamer-siRNA delivery system for HIV-1 Therapy |
10/04/2011 | US8030289 Oligonucleotide and use thereof |
10/04/2011 | US8030287 DNA vaccine against North American spring viremia of carp virus |